White House calls on FDA to consider overall effect of regs
The US FDA must consider the cumulative impact of regulations on small firms to prevent its actions from suppressing growth, the White House said.
The US FDA must consider the cumulative impact of regulations on small firms to prevent its actions from suppressing growth, the White House said.
The US FDA is keeping its estimate of the burden imposed by electronic facility registration despite some industry opposition.
Cetero Research has filed for bankruptcy protection eight months after the US FDA said it manipulated samples and faked documents.
Planning supply chains early is an important part of maintaining margins but is often overlooked by Pharmas too focused on developing the next product in an era of patent expiry says industry consultant.
Bend Research has launched a formulation and production optimisation service for botherapeutics and vaccine makers, leveraging techs developed with Big Pharma partners.